Jeffrey P. Kahn – författare
Visar alla böcker från författaren Jeffrey P. Kahn. Handla med fri frakt och snabb leverans.
6 produkter
6 produkter
2 527 kr
Skickas inom 5-8 vardagar
Natural disasters and cholera outbreaks. Ebola, SARS, and concerns over pandemic flu. HIV and AIDS. E. coli outbreaks from contaminated produce and fast foods. Threats of bioterrorism. Contamination of compounded drugs. Vaccination refusals and outbreaks of preventable diseases. These are just some of the headlines from the last 30-plus years highlighting the essential roles and responsibilities of public health, all of which come with ethical issues and the responsibilities they create.Public health has achieved extraordinary successes. And yet these successes also bring with them ethical tension. Not all public health successes are equally distributed in the population; extraordinary health disparities between rich and poor still exist. The most successful public health programs sometimes rely on policies that, while improving public health conditions, also limit individual rights. Public health practitioners and policymakers face these and other questions of ethics routinely in their work, and they must navigate their sometimes competing responsibilities to the health of the public with other important societal values such as privacy, autonomy, and prevailing cultural norms. This Oxford Handbook provides a sweeping and comprehensive review of the current state of public health ethics, addressing these and numerous other questions. Taking account of the wide range of topics under the umbrella of public health and the ethical issues raised by them, this volume is organized into fifteen sections. It begins with two sections that discuss the conceptual foundations, ethical tensions, and ethical frameworks of and for public health and how public health does its work. The thirteen sections that follow examine the application of public health ethics considerations and approaches across a broad range of public health topics. While chapters are organized into topical sections, each chapter is designed to serve as a standalone contribution. The book includes 73 chapters covering many topics from varying perspectives, a recognition of the diversity of the issues that define public health ethics in the U.S. and globally. This Handbook is an authoritative and indispensable guide to the state of public health ethics today.
542 kr
Skickas inom 5-8 vardagar
Why do so many people suffer the slings and arrows of outrageous angst? Some twenty percent of us are afflicted with common Anxiety and Depressive disorders. That's not just nervous or scared or sad - that is painful dysfunction without obvious benefit. This angst comes from an evolutionary inheritance that biologically shaped us into social communities. There are just five specific diagnostic subtypes that account for most of this modern-day angst: Panic Anxiety, Social Anxiety, OCD, Atypical Depression and Melancholic Depression. Each of the five comes from primeval social instincts that told our ancestors how to improve survival of their community DNA. These instincts are also very much alive and unfettered in other species today. Their potential link to our human distress was anticipated by both Darwin and Freud. We humans have greater instinctive consciousness than other creatures. Rational thoughts let us defy biological social instructions. One result of this uniquely human skill is that over-ridden social instincts complain to us in the painful language of emotional disorders. A few of us even tackle this pain head-on, in ways that can advance our intellectual creativity, social performance, and productivity. Our human intellectual abilities owe as much to our unique social software as to our greater brain processing power. Civilization is built upon our ability to maintain social harmony with ethics and government, and to find solace in technology, religion and beer.This novel theoretical synthesis offers a new framework for understanding what our knowledge of psychiatric neuroscience, clinical research, diagnosis and treatment. The central theory is explained in everyday language. It is supported by clinical observation, straightforward accounts of complex science, animal research, and quotes from both ancient writings and modern humor and lyrics. This fascinating new synthesis is written for the general public, mental health professionals and academic researchers alike.
509 kr
Skickas inom 5-8 vardagar
Justice is foundational to discussion, debate, and policy making surrounding biomedical research. Time-tested for more than 20 years, Beyond Consent examines the concept of justice and its application to research with human subjects, through multiple lenses of research populations of people who are sick (including those needing emergency medical care), cognitively impaired, children, captive and convenient (such as prisoners), women, racial minorities, communities, and living in international settings. This second edition includes new chapters on today's leading-edge topics as well as updated chapters that consider what has changed, and what new matters have arisen. The result is a fresh treatment of the latest issues and concepts of justice in research examined by multidisciplinary scholars.This volume is a vital resource for students and scholars of bioethics, medicine, and public health policy; as well as for members of institutional review boards, research administrators, and policy makers.
412 kr
Tillfälligt slut
For many years, experiments using chimpanzees have been instrumental in advancing scientific knowledge and have led to new medicines to prevent life-threatening and debilitating diseases. However, recent advances in alternate research tools have rendered chimpanzees largely unnecessary as research subjects. The Institute of Medicine, in collaboration with the National Research Council, conducted an in-depth analysis of the scientific necessity for chimpanzees in NIH-funded biomedical and behavioral research. The committee concludes that while the chimpanzee has been a valuable animal model in the past, most current biomedical research use of chimpanzees is not necessary, though noted that it is impossible to predict whether research on emerging or new diseases may necessitate chimpanzees in the future.
Psychotic Disorders
Comorbidity Detection Promotes Improved Diagnosis And Treatment
Häftad, Engelska, 2021
1 056 kr
Skickas inom 5-8 vardagar
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research.? Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.��
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis.? But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.��
The chapter authors expertly detail the data supporting this innovative approach.? They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options.? Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.�
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
181 kr
Skickas inom 5-8 vardagar
As nations race to hone contact-tracing efforts, the world's experts consider strategies for maximum transparency and impact.As public health professionals around the world work tirelessly to respond to the COVID-19 pandemic, it is clear that traditional methods of contact tracing need to be augmented in order to help address a public health crisis of unprecedented scope. Innovators worldwide are racing to develop and implement novel public-facing technology solutions, including digital contact tracing technology. These technological products may aid public health surveillance and containment strategies for this pandemic and become part of the larger toolbox for future infectious outbreak prevention and control. As technology evolves in an effort to meet our current moment, Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies—a rapid research and expert consensus group effort led by Dr. Jeffrey P. Kahn of the Johns Hopkins Berman Institute of Bioethics in collaboration with the university's Center for Health Security—carried out an in-depth analysis of the technology and the issues it raises. Drawing on this analysis, they produced a report that includes detailed recommendations for technology companies, policymakers, institutions, employers, and the public. The project brings together perspectives from bioethics, health security, public health, technology development, engineering, public policy, and law to wrestle with the complex interactions of the many facets of the technology and its applications.This team of experts from Johns Hopkins University and other world-renowned institutions has crafted clear and detailed guidelines to help manage the creation, implementation, and application of digital contact tracing. Digital Contact Tracing for Pandemic Response is the essential resource for this fast-moving crisis.Contributors: Joseph Ali, JD; Anne Barnhill, PhD; Anita Cicero, JD; Katelyn Esmonde, PhD; Amelia Hood, MA; Brian Hutler, Phd, JD; Jeffrey P. Kahn, PhD, MPH; Alan Regenberg, MBE; Crystal Watson, DrPH, MPH; Matthew Watson; Robert Califf, MD, MACC; Ruth Faden, PhD, MPH; Divya Hosangadi, MSPH; Nancy Kass, ScD; Alain Labrique, PhD, MHS, MS; Deven McGraw, JD, MPH, LLM; Michelle Mello, JD, PhD; Michael Parker, BEd (Hons), MA, PhD; Stephen Ruckman, JD, MSc, MAR; Lainie Rutkow, JD, MPH, PhD; Josh Sharfstein, MD; Jeremy Sugarman, MD, MPH, MA; Eric Toner, MD; Mar Trotochaud, MSPH; Effy Vayena, PhD; Tal Zarsky, JSD, LLM, LLB